Ras-Related Mutants Identified in Young-Onset Colorectal Cancer Display Divergent Phenotypes and Retain Their Pro-Angiogenic Effects
Cells · 2026
DOI: 10.3390/cells15040349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Andrei Phillip L David und 5 weiteren Autor:innen. Beteiligte Einrichtung: Disease Molecular Biology and Epigenetics Laboratory, National Institute of Molecular Biology and Biotechnology, University of the Philippines Dilima…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Mutation, Neovascularization, Pathologic, Monomeric GTP-Binding Proteins. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of the Philippines System, Philippine Council for Health Research and Development, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman.
Abstract (Originalsprache)
The Ras-related (RRAS) gene is a member of the Ras superfamily and remains largely uncharacterized compared to KRAS, NRAS, and HRAS. Its role in tumorigenesis remains poorly documented, as evidenced by its lack of canonical mutations in any cancer type. This study investigated the effects of the novel RRAS R78W and E63D mutants—identified in Filipino young-onset colorectal cancer (YO-CRC) patients—on cancer hallmarks. In silico analysis was performed to predict the effect of the mutations on RRAS structure. F-actin staining of transfected NIH3T3 cells displayed massive cytoskeletal remodeling and formation of migratory and invasive structures. RRAS R78W enhanced migration when compared to wild-type RRAS in NIH3T3 and HCT116 cells, whereas neither mutant affected invasive capacity. Both mutants did not abolish the pro-angiogenic ability of wild-type RRAS in endothelial tube formation assays. RRAS E63D conferred resistance to apoptosis in both cell lines. Both mutants had no effect on cellular proliferation in either cell line. Overexpression of both mutants did not increase Akt and Erk1/2 phosphorylation. In silico analysis further suggests that the mutations confer increased GEF-binding ability versus wild-type. Results of the study highlight the need to characterize Ras isoform- and mutation-specific phenotypic effects, which may have repercussions in CRC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Disease Molecular Biology and Epigenetics Laboratory, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Quezon City 1101, Philippines.
- Division of Medical Oncology, Department of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
ORCID-Profile: Dennis L Sacdalan, Reynaldo L Garcia
Förderung
- University of the Philippines System
- Philippine Council for Health Research and Development
- National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman
Zitieren
APA
David, A. P. L., Galvez, M. I. P., Chua, S. A. A., Leaño, D. M. G., Sacdalan, D. L., & Garcia, R. L. (2026). Ras-Related Mutants Identified in Young-Onset Colorectal Cancer Display Divergent Phenotypes and Retain Their Pro-Angiogenic Effects. Cells. https://doi.org/10.3390/cells15040349
Vancouver
David APL, Galvez MIP, Chua SAA, Leaño DMG, Sacdalan DL, Garcia RL. Ras-Related Mutants Identified in Young-Onset Colorectal Cancer Display Divergent Phenotypes and Retain Their Pro-Angiogenic Effects. Cells. 2026. doi:10.3390/cells15040349
BibTeX
@article{David2026,
author = {David, Andrei Phillip L and Galvez, Mariko Isabelle P and Chua, Sidney Allen A and Leaño, Dominique Mickai G and Sacdalan, Dennis L and Garcia, Reynaldo L},
title = {Ras-Related Mutants Identified in Young-Onset Colorectal Cancer Display Divergent Phenotypes and Retain Their Pro-Angiogenic Effects},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15040349}
}
EUVIMED